Ebitda Perubahan Tanggal
AbbVie USD 6.91B 3.22B 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 5.8B 1.25B 2026-09
Arrowhead Research USD -212.62M 64.94M 2026-09
Astellas Pharma JPY 182.02B 53.22B 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
Bayer EUR 1.62B 529M 2026-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 54.32M 167.99M 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Daiichi Sankyo JPY 116.06B 14.46B 2026-06
Eli Lilly USD 9.46B 3.54B 2026-09
Exelixis USD 275.36M 19.96M 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -95.22M 9.99M 2026-09
Merck USD 1.42B 2.97B 2026-06
Moderna USD -687M 571M 2026-06
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novartis USD 8.62B 2.14B 2026-09
Novartis USD 5.36B 45M 2026-09
Pfizer USD 6.36B 350M 2026-09
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Vertex Pharmaceuticals USD 888.6M 436.6M 2026-09